FLNA (FLNA) Stock Price & Analysis
FLNA (FLNA) fell 0.99% to USD 0.82 as of September 8, 2026 at 09:02 UTC, according to Nexqual real-time market data.
FLNA last closed at USD 0.82; the session ranged USD 0.8–0.85 on volume of 285,998 shares. Market capitalization is —, with a 52-week range of USD 0.8–4.98 (NCM). Source: Nexqual, September 8, 2026 at 09:02 UTC.
Key Statistics (as of September 8, 2026 at 09:02 UTC)
| Price | USD 0.82 |
|---|---|
| Change | ▼ 0.99% (down) |
| Previous Close | USD 0.82 |
| Open | USD 0.82 |
| Day Range | USD 0.8 – 0.85 |
| 52-Week Range | USD 0.8 – 4.98 |
| Volume | 285,998 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (FLNA)
Nexqual's technical model rates FLNA "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.47 (neutral) |
| vs SMA50 | Below (USD 1.01) |
| MACD | -0.04 (negative) |
From FLNA's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OCGN | Ocugen, Inc. | USD 1.36 | ▲ 3.03% |
| AVXL | Anavex Life Sciences Corp. | USD 2.86 | ▼ 1.04% |
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 2.04% |
| BNGO | Bionano Genomics, Inc. | USD 1.2 | ▼ 5.51% |
| NVAX | Novavax, Inc. | USD 10.22 | ▼ 0.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:02 UTC. This page is informational and not investment advice.